Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Puverel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Topics in Developmental Biology|January 5, 2013
RanBPM, a scaffolding protein for gametogenesisSandrine Puverel, Lino Tessarollo
The Journal of Comparative Neurology|November 13, 2008
Prokineticin receptor 2 expression identifies migrating neuroblasts and their subventricular zone transient-amplifying progenitors in adult miceSandrine Puverel, Hiroko Nakatani, Carlos Parras, et al.
Development (Cambridge, England)|May 13, 2011
RanBPM is essential for mouse spermatogenesis and oogenesisSandrine Puverel, Colleen Barrick, Susanna Dolci, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Molecular cloning and localization of a PMCA P-type calcium ATPase from the coral Stylophora pistillataDidier Zoccola, Eric Tambutté, Emmanuelle Kulhanek, et al.
The Journal of Cell Biology|September 9, 2015
BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activationGianluca Fulgenzi, Francesco Tomassoni-Ardori, Lucia Babini, et al.
Oncotarget|November 12, 2016
RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cellsSandrine Puverel, Erkan Kiris, Satyendra Singh, et al.
Molecular Microbiology|November 30, 2005
Ca2+-dependent lipid binding and membrane integration of PopA, a harpin-like elicitor of the hypersensitive response in tobaccoJudith Racapé, Lassaad Belbahri, Stefan Engelhardt, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
The Lancet. Haematology|July 27, 2024
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 studyAlex F Herrera, Jasmine Zain, Kerry J Savage, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Topics in Developmental Biology|January 5, 2013
RanBPM, a scaffolding protein for gametogenesisSandrine Puverel, Lino Tessarollo
The Journal of Comparative Neurology|November 13, 2008
Prokineticin receptor 2 expression identifies migrating neuroblasts and their subventricular zone transient-amplifying progenitors in adult miceSandrine Puverel, Hiroko Nakatani, Carlos Parras, et al.
Development (Cambridge, England)|May 13, 2011
RanBPM is essential for mouse spermatogenesis and oogenesisSandrine Puverel, Colleen Barrick, Susanna Dolci, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Molecular cloning and localization of a PMCA P-type calcium ATPase from the coral Stylophora pistillataDidier Zoccola, Eric Tambutté, Emmanuelle Kulhanek, et al.
The Journal of Cell Biology|September 9, 2015
BDNF modulates heart contraction force and long-term homeostasis through truncated TrkB.T1 receptor activationGianluca Fulgenzi, Francesco Tomassoni-Ardori, Lucia Babini, et al.
Oncotarget|November 12, 2016
RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cellsSandrine Puverel, Erkan Kiris, Satyendra Singh, et al.
Molecular Microbiology|November 30, 2005
Ca2+-dependent lipid binding and membrane integration of PopA, a harpin-like elicitor of the hypersensitive response in tobaccoJudith Racapé, Lassaad Belbahri, Stefan Engelhardt, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Leukemia & Lymphoma|October 17, 2019
Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignanciesTanya Siddiqi, Paul Frankel, Jan H Beumer, et al.
The Lancet. Haematology|July 27, 2024
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 studyAlex F Herrera, Jasmine Zain, Kerry J Savage, et al.
Pageof 2